Clinical Trials on Rewarming by External Heat to the Head in Japan
Total 147 results
-
Bristol-Myers SquibbOno Pharma USA IncCompletedCancer of Head and Neck | Cancer of the Head | Cancer of the NeckJapan
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Kurume UniversityUnknownTo Evaluate the Effect of Pioglitazone on Glucose Metabolism of Fat Tissue by Using FDG-PET/CT ImagingJapan
-
Merck KGaA, Darmstadt, GermanyCompletedSquamous Cell Carcinoma of the Head and NeckJapan
-
University of YamanashiUnknown
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Stryker Japan K.K.UnknownOsteoarthritis | Rheumatoid Arthritis | Avascular Necrosis of the Femoral HeadJapan
-
PfizerCompletedSquamous Cell Carcinoma of the Head and Neck (SCCHN)United States, Spain, Korea, Republic of, Czechia, Taiwan, Serbia, Japan, Slovakia, Mexico, Romania, Hungary, Italy, Poland, Russian Federation, Ukraine
-
Hokkaido University HospitalMerck Sharp & Dohme LLCRecruiting
-
HekabioCompletedBreast Cancer | Head and Neck CancerJapan
-
Southern Tohoku BNCT Research CenterActive, not recruitingHead and Neck Cancer | Squamous Cell CarcinomaJapan
-
Hoffmann-La RocheTerminatedLocally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)United States, Korea, Republic of, Canada, Australia, Russian Federation, United Kingdom, Belgium, Brazil, China, France, Italy, Portugal, Spain, Japan, India, Thailand, Ukraine, Taiwan, Poland, Turkey, Hungary, South Africa, Germany
-
AstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckUnited States, Italy, Korea, Republic of, Spain, Greece, Germany, Japan
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedSquamous Cell Carcinoma of the Head and NeckUnited States, Italy, Japan, Spain, Taiwan, Korea, Republic of, France, Poland, Russian Federation, Turkey
-
AstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckUnited States, Canada, France, Italy, Spain, United Kingdom, Poland, Taiwan, Thailand, Vietnam, Belgium, Germany, Korea, Republic of, Brazil, India, Japan, Philippines, Russian Federation, Austria, Ukraine, Greece, Slovakia, Romania
-
Bristol-Myers SquibbCompletedHead and Neck CancerJapan
-
AstraZenecaCompletedRecurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHNUnited States, France, Italy, Spain, Belgium, Czechia, Romania, Taiwan, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Australia, Germany, Israel, Serbia, Bulgaria, Ukraine, Argentina, Poland, Chile, Croatia, Georgia
-
GlaxoSmithKlineiTeos TherapeuticsRecruitingNeoplasms, Head and NeckUnited States, Italy, Spain, Taiwan, Germany, Greece, Korea, Republic of, Romania, Sweden, Turkey, Canada, Argentina, Finland, Brazil, Japan, Poland, Portugal, France, Denmark, Hungary, Norway
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedHead and Neck CancerItaly, United States, Israel, Japan, Australia, Austria, Brazil, France, Germany, Greece, Ireland, Korea, Republic of, Mexico, Poland, Spain, Switzerland, Taiwan, United Kingdom
-
Comprehensive Support Project for Oncology ResearchActive, not recruitingStomach Cancer | Breast Cancer | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Squamous Cell Carcinoma of the Head and Neck | Endometrial Cancer | Liver CancerJapan
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedSquamous Cell Carcinoma of the Head and NeckBrazil, Italy, United Kingdom, United States, Hong Kong, France, Netherlands, Germany, Argentina, Canada, Japan, Korea, Republic of, Spain, Switzerland, Taiwan
-
PfizerTerminatedSquamous Cell Carcinoma of the Head and NeckUnited States, Spain, China, Taiwan, France, Australia, Hungary, Korea, Republic of, Germany, Japan, Switzerland, Ireland, Israel, United Kingdom, Italy, Poland, Belgium, Canada, Greece, Portugal, Austria, Russian Federation
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; GORTEC (Head and Neck Oncology and Radiotherapy...Active, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States, Spain, Korea, Republic of, Taiwan, China, Argentina, France, Japan, Israel, United Kingdom, Belgium, Germany, Portugal, Greece, Italy, Georgia, Australia, Czechia, Brazil, Canada, Austria, Russian Federation, Switzerland and more
-
Japanese Foundation for Cancer ResearchHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Osaka UniversityRecruitingThyroid CancerJapan
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Wakayama Medical UniversityUnknown
-
Eisai Co., Ltd.Completed
-
Hokkaido Gastrointestinal Cancer Study GroupHokkaido University HospitalCompleted
-
Hokkaido Gastrointestinal Cancer Study GroupHokkaido University HospitalCompleted
-
Aichi Cancer CenterCompleted
-
Kinki UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Hamamatsu UniversityCompletedEsophageal Cancer | Squamous Cell CarcinomaJapan
-
Aichi Cancer CenterUnknown
-
BayerActive, not recruiting
-
AstraZenecaInnate PharmaActive, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States, France, Italy, Spain, Belgium, Canada, Taiwan, Switzerland, Korea, Republic of, Japan, Poland, Russian Federation, United Kingdom, Austria, Brazil, Germany, Netherlands, Portugal, Australia, Philippines, Bulgaria, G... and more
-
University of ToyamaUnknown
-
National Cancer Center Hospital EastDaiichi Sankyo Co., Ltd.RecruitingGastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaJapan
-
CellSeed Inc.Terminated
-
Oncolys BioPharma IncUnknownEsophageal CancerJapan
-
Nagasaki UniversityCompletedIschemia | Esophageal Neoplasms | Anastomotic Leak | ConstrictionJapan
-
Nagasaki UniversityCompletedIschemia | Esophageal Neoplasms | Anastomotic Leak | ConstrictionJapan
-
Rakuten Medical, Inc.RecruitingHead and Neck CancerUnited States, Taiwan, Japan, India, Ukraine
-
Keio UniversityRecruitingEsophageal Squamous Cell CarcinomaJapan
-
National Cancer Center, JapanRecruitingEsophageal Squamous Cell CarcinomaJapan
-
National Cancer Center Hospital EastBayer Yakuhin, Ltd.Active, not recruitingGastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Eisai Co., Ltd.Completed
-
Wakayama Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknown